journal article·2025-11Open access

High‐Throughput Strategies for Streamlining Lipid Nanoparticle Development Pipeline

Lois Lam, Stephanie Watson, Yogambha Ramaswamy, Gurvinder Singh

Advanced Science· Volume 12· Issue 42

Abstract

Abstract Lipid nanoparticles (LNPs) have become clinically validated nanocarriers for nucleic acid delivery, enabling applications in mRNA vaccines and therapies for cancer, ocular, and infectious diseases. Identifying LNPs formulations with optimal physicochemical and pharmacokinetic properties using traditional low‐throughput methods is resource‐intensive and impractical for evaluating large libraries. Recent advances in automation, high‐throughput platforms for lipid synthesis, characterization, and screening tools are transforming the landscape of LNP formulation. These strategies enable rapid multi‐parametric generation and evaluation of hundreds to thousands of formulations across key properties such as size, charge, stability, biodistribution, cellular uptake, and intracellular trafficking. In parallel, advanced biomimetic models and in vivo multiplexed barcoding screening strategies provide deeper insights into tissue targeting and therapeutic delivery outcomes. This review provides an integrated framework that combines automation with high‐throughput combinatorial synthesis, characterization, and in vitro/in vivo screening tools. In this development pipeline, performance benchmarks applied at each step systematically exclude suboptimal candidates, ensuring that only clinically viable LNP candidates advance. Future directions, including automation, high‐throughput, and closed‐loop machine learning guided design strategies, are further discussed to advance the development of next‐generation LNP therapeutics and accelerate their translation from bench to bedside.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Lipid Membrane Structure and Behavior · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The School of Biomedical Engineering Faculty of IT and Engineering Sydney Nano Institute The University of Sydney Camperdown New South Wales 2008 Australia

Sydney Medical School Faculty of Medicine and Health Sydney Nano Institute The University of Sydney Camperdown New South Wales 2008 Australia

References (100+)

Show source-provided references
1. 10.1038/s41551-021-00698-w10.1038/s41551-021-00698-w ↗
2. 10.1038/s41565-021-00898-010.1038/s41565-021-00898-0 ↗
3. 10.2147/IJN.S14631510.2147/IJN.S146315 ↗
4. 10.1007/s10311-018-00841-110.1007/s10311-018-00841-1 ↗
5. 10.1038/s41570-017-005410.1038/s41570-017-0054 ↗
6. 10.1038/nnano.2017.4510.1038/nnano.2017.45 ↗
7. 10.1021/acs.analchem.7b0533010.1021/acs.analchem.7b05330 ↗
8. 10.1021/jacs.0c0702210.1021/jacs.0c07022 ↗
9. 10.1038/ncomms1347510.1038/ncomms13475 ↗
10. 10.1021/acsnano.5b0643910.1021/acsnano.5b06439 ↗
11. 10.1016/j.nantod.2024.10214910.1016/j.nantod.2024.102149 ↗
12. 10.1021/acs.nanolett.0c0138610.1021/acs.nanolett.0c01386 ↗
13. 10.1039/C8NR02278J10.1039/C8NR02278J ↗
14. 10.1021/acsnano.3c0118610.1021/acsnano.3c01186 ↗
15. 10.1016/j.nantod.2020.10100810.1016/j.nantod.2020.101008 ↗
16. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
17. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
18. 10.1016/j.addr.2015.09.01210.1016/j.addr.2015.09.012 ↗
19. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
20. 10.1038/s42003-021-02441-210.1038/s42003-021-02441-2 ↗
21. 10.1002/adtp.20200011110.1002/adtp.202000111 ↗
22. 10.1016/j.addr.2022.11441610.1016/j.addr.2022.114416 ↗
23. 10.1016/j.addr.2003.12.00210.1016/j.addr.2003.12.002 ↗
24. 10.1016/j.scitotenv.2024.17224010.1016/j.scitotenv.2024.172240 ↗
25. 10.1016/j.jconrel.2004.02.02910.1016/j.jconrel.2004.02.029 ↗
26. 10.1016/S0169-409X(02)00118-710.1016/S0169-409X(02)00118-7 ↗
27. 10.1016/j.ijpharm.2008.10.00310.1016/j.ijpharm.2008.10.003 ↗
28. 10.1038/s41565-019-0591-y10.1038/s41565-019-0591-y ↗
29. 10.1016/j.addr.2020.06.01710.1016/j.addr.2020.06.017 ↗
30. 2025
31. 10.1021/acsnano.3c0111710.1021/acsnano.3c01117 ↗
32. 10.1038/nnano.2012.16810.1038/nnano.2012.168 ↗
33. 10.1016/j.biomaterials.2021.12082610.1016/j.biomaterials.2021.120826 ↗
34. 10.1016/j.jconrel.2022.02.01710.1016/j.jconrel.2022.02.017 ↗
35. 10.1002/adhm.20220303310.1002/adhm.202203033 ↗
36. 10.1039/D1NR06858J10.1039/D1NR06858J ↗
37. 10.1016/j.addr.2018.04.00110.1016/j.addr.2018.04.001 ↗
38. 10.1002/smtd.20170037510.1002/smtd.201700375 ↗
39. 10.1016/j.apsb.2022.04.01310.1016/j.apsb.2022.04.013 ↗
40. 10.1021/jacsau.1c0031310.1021/jacsau.1c00313 ↗
41. 10.1016/j.jconrel.2025.11390610.1016/j.jconrel.2025.113906 ↗
42. 10.1016/j.jconrel.2025.11394510.1016/j.jconrel.2025.113945 ↗
43. 10.1038/s41467-021-27493-010.1038/s41467-021-27493-0 ↗
44. 10.1038/nbt140210.1038/nbt1402 ↗
45. 10.1016/j.cbpa.2017.03.01710.1016/j.cbpa.2017.03.017 ↗
46. 10.1016/j.drudis.2022.06.00810.1016/j.drudis.2022.06.008 ↗
47. 10.1038/s41427-025-00595-710.1038/s41427-025-00595-7 ↗
48. 10.1002/cmdc.20240019910.1002/cmdc.202400199 ↗
49. 10.1021/cm402180t10.1021/cm402180t ↗
50. 10.3389/fphar.2022.103300310.3389/fphar.2022.1033003 ↗
51. 10.1016/j.progpolymsci.2006.03.00110.1016/j.progpolymsci.2006.03.001 ↗
52. 10.1038/s41587-023-01679-x10.1038/s41587-023-01679-x ↗
53. 10.1073/pnas.230947212010.1073/pnas.2309472120 ↗
54. 10.1038/s41587-019-0247-310.1038/s41587-019-0247-3 ↗
55. 10.1073/pnas.240957212210.1073/pnas.2409572122 ↗
56. 10.1002/anie.20231040110.1002/anie.202310401 ↗
57. 10.1021/jacs.5c0412310.1021/jacs.5c04123 ↗
58. 10.1038/s41551-024-01267-710.1038/s41551-024-01267-7 ↗
59. 10.1186/s12951-024-02919-110.1186/s12951-024-02919-1 ↗
60. 10.1038/s41557-024-01557-210.1038/s41557-024-01557-2 ↗
61. 10.1038/s41467-024-50619-z10.1038/s41467-024-50619-z ↗
62. “Useful Numbers for Cell Culture‐AU ”https://www.thermofisher.com/au/en/home/references/gibco‐cell‐culture‐basics/cell‐culture‐protocols/cell‐culture‐useful‐numbers.html (accessed: September 2024).
63. 10.1021/acsnano.2c0782210.1021/acsnano.2c07822 ↗
64. 10.1038/s41467-024-45422-910.1038/s41467-024-45422-9 ↗
65. 10.1002/adfm.20231062310.1002/adfm.202310623 ↗
66. 10.1038/s41467-022-31993-y10.1038/s41467-022-31993-y ↗
67. 10.1038/s41551-023-01131-010.1038/s41551-023-01131-0 ↗
68. 10.1038/s41576-022-00466-910.1038/s41576-022-00466-9 ↗
69. 10.1111/cts.1369510.1111/cts.13695 ↗
70. 10.1021/acs.nanolett.3c0350910.1021/acs.nanolett.3c03509 ↗
71. 10.1016/j.jconrel.2015.08.00810.1016/j.jconrel.2015.08.008 ↗
72. 10.1002/adma.20200297410.1002/adma.202002974 ↗
73. “Human Liver‐on‐a‐Chip to Predict and De‐Risk Next Gen Therapeutics | Emulate ”https://emulatebio.com/resources/human‐liver‐on‐a‐chip‐to‐predict‐and‐de‐risk‐next‐gen‐therapeutics‐boston‐mps‐day/ (accessed: July 2025).
74. “LNP Cost Calculator | Emulate ”https://emulatebio.com/lnp‐cost‐calculator/ (accessed: July 2025).
75. 10.1038/nbt.346010.1038/nbt.3460 ↗
76. 10.1038/s43018-019-0018-610.1038/s43018-019-0018-6 ↗
77. 10.1038/s43018-024-00814-010.1038/s43018-024-00814-0 ↗
78. 10.1126/science.abm555110.1126/science.abm5551 ↗
79. 10.1073/pnas.181127611510.1073/pnas.1811276115 ↗
80. 10.1021/acs.nanolett.8b0043210.1021/acs.nanolett.8b00432 ↗
81. 10.1038/s41563-021-01047-710.1038/s41563-021-01047-7 ↗
82. 10.1038/s41392-023-01536-y10.1038/s41392-023-01536-y ↗
83. 10.1021/acsnano.4c0117110.1021/acsnano.4c01171 ↗
84. 10.1016/j.jconrel.2023.04.00510.1016/j.jconrel.2023.04.005 ↗
85. 10.1073/pnas.162087411410.1073/pnas.1620874114 ↗
86. 10.1016/j.jconrel.2019.10.02810.1016/j.jconrel.2019.10.028 ↗
87. 10.1021/acsnano.8b0364010.1021/acsnano.8b03640 ↗
88. 10.1021/acs.nanolett.2c0113310.1021/acs.nanolett.2c01133 ↗
89. 10.1128/AEM.71.12.8966-8969.200510.1128/AEM.71.12.8966-8969.2005 ↗
90. 10.1038/nmeth.177810.1038/nmeth.1778 ↗
91. 10.1016/j.cell.2015.05.00210.1016/j.cell.2015.05.002 ↗
92. 10.1038/s41580-021-00417-y10.1038/s41580-021-00417-y ↗
93. 10.1073/pnas.210925611810.1073/pnas.2109256118 ↗
94. 10.1038/s41467-022-32281-510.1038/s41467-022-32281-5 ↗
95. 10.1002/adma.20160694410.1002/adma.201606944 ↗
96. 10.1002/adma.20190225110.1002/adma.201902251 ↗
97. 10.1073/pnas.220784111910.1073/pnas.2207841119 ↗
98. 10.1038/nnano.2012.20710.1038/nnano.2012.207 ↗
99. 10.1021/acs.accounts.1c0054410.1021/acs.accounts.1c00544 ↗
100. 10.1038/s41578-022-00529-710.1038/s41578-022-00529-7 ↗